XPO1 and pancreatic adenocarcinoma: High expression of XPO1 has been reported in various tumors, including pancreatic adenocarcinoma, gastric cancer, neuroblastoma, and hematologic tumors, and is strongly associated with poor prognosis.6, 7, 8, 9